Skip to content
Back to Guavy Wire
Forex

Swiss National Bank Invests $1 Million in Biotech Firm Monte Rosa Therapeutics

Instruments
CHF
Share

The Swiss National Bank has made an investment of $1 million in Monte Rosa Therapeutics, Inc. (NASDAQ:GLUE), as per its recent filing with the Securities and Exchange Commission.

The bank purchased a total of 61,100 shares of the company's stock in the first quarter, valued at approximately $1,005,000.

This investment accounts for about 0.07% of Monte Rosa Therapeutics' outstanding shares at the end of the most recent reporting period.

More on Forex

Disclaimer: Guavy is a data and market intelligence provider, not an investment advisor. The information, signals, and market analysis provided by the Guavy API and related services are for informational purposes only and are not intended as financial advice, investment recommendations, or an endorsement of any particular trading strategy. Trading in volatile markets, including cryptocurrency, carries significant risk and may not be suitable for all investors. Past performance is not indicative of future results. Users should consult with a qualified financial professional before making any investment decisions. Guavy makes no guarantee of trading profits or financial returns.

Real-time market sentiment intelligence for apps, funds & agents

Location

729 55 Ave SW
Calgary AB T2V 0G4
Canada

© 2026 Guavy Inc